News
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...
Eli Lilly has signed a deal worth US$1.3 billion with privately held Superluminal Medicines to discover and develop ...
The FDA’s announcement of Papzimeos’ approval contained an unusual quote from newly reinstated CBER director Vinay Prasad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback